Financial reports
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
21 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
17 Mar 22
Current reports
8-K
Departure of Directors or Certain Officers
12 Mar 24
8-K
LifeStance Reports Fourth Quarter and Full Year 2023 Results
27 Feb 24
8-K
Results of Operations and Financial Condition
2 Feb 24
8-K
LifeStance Reports Third Quarter 2023 Results
7 Nov 23
8-K
LifeStance Reports Second Quarter 2023 Results
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 23
8-K
LifeStance Reports First Quarter 2023 Results
9 May 23
8-K
LifeStance Reports Fourth Quarter and Full Year 2022 Results
7 Mar 23
8-K
LifeStance Reports Third Quarter 2022 Results
8 Nov 22
8-K
Lifestance Health Appoints J. Michael Bruff As New Business Tranformation Officer; David Bourdon As Chief Financial Officer
3 Nov 22
Registration and prospectus
S-8
Registration of securities for employees
28 Feb 24
S-8
Registration of securities for employees
9 Mar 23
S-8
Registration of securities for employees
17 Mar 22
S-8
Registration of securities for employees
14 Jun 21
424B4
Prospectus supplement with pricing info
11 Jun 21
8-A12B
Registration of securities on exchange
10 Jun 21
S-1/A
IPO registration (amended)
8 Jun 21
S-1/A
IPO registration (amended)
1 Jun 21
S-1
IPO registration
17 May 21
DRS/A
Draft registration statement (amended)
13 May 21
Other
UPLOAD
Letter from SEC
6 Oct 23
CORRESP
Correspondence with SEC
5 Oct 23
UPLOAD
Letter from SEC
3 Oct 23
CORRESP
Correspondence with SEC
12 Sep 23
UPLOAD
Letter from SEC
14 Aug 23
CERT
Certification of approval for exchange listing
10 Jun 21
EFFECT
Notice of effectiveness
10 Jun 21
CORRESP
Correspondence with SEC
8 Jun 21
CORRESP
Correspondence with SEC
8 Jun 21
CORRESP
Correspondence with SEC
8 Jun 21